Twitter Facebook LinkedIn
Login »
December 16, 2014

FDA, Joint Commission cite safety concerns with power morcellation

By: OR Manager
Tags: , , ,
Share

Reports about problems associated with power morcellation in gynecologic surgery led to safety warnings in November 2014 by the Food and Drug Administration (FDA) and the Joint Commission.

Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:

LOGIN
  Join the OR Manager Community! OR Manager is the trusted source for perioperative leaders, providing critical information, analysis, and best practices for management of the surgical suite. Join as a Premium Subscriber to access all articles online including archives, the digital issue of OR Manager each month, eligibility for CE contact hours, registration discounts on conferences and more. We also offer a complimentary Plus subscription to those who qualify and a complimentary Community subscription.

Explore Subscription Options

Please contact our Customer Service Team if you are unable to log in at [email protected] or 1-888-707-5814.

Previous Story Next Story
Related Stories
Accreditation updates from The Joint Commission, CMS

Takeaways Many OR managers said they were overdue for a…

Find out more

Tackling internal objections to single-use device reprocessing

Many healthcare professionals are aware of single-use device reprocessing and…

Find out more

A team approach to reducing instrumentation, costs during the age of COVID-19

ORs rebounding from the financial impact of COVID-19 are looking…

Find out more

Related Topics

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
June 2023

Free Daily News

Read More »
Video Spotlight
Webinar Center
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity
Live chat by BoldChat